Roche Diagnostics delivers molecular testing instruments to boost Ebola lab capacity in DRC
Roche Diagnostics shipped two molecular testing instruments to Congo’s INSP to expand Ebola testing capacity in the DRC. The equipment targets Bundibugyo virus detection, and the agency will validate it locally in Bunia.
1. Testing capacity expansion
Roche Diagnostics shipped two molecular testing instruments to Congo’s INSP to expand Ebola testing capacity in the DRC, with the equipment targeting Bundibugyo virus detection. INSP will validate the instruments locally in Bunia; additional test shipments and instrument deployments are expected once validation is complete. UN data as of Sept. 28, 2026, showed 8,067 confirmed cases and 3,901 deaths, a case fatality rate of 48.4%.
